These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6134565)

  • 21. A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.
    Green JR; Mansfield JC; Gibson JA; Kerr GD; Thornton PC
    Aliment Pharmacol Ther; 2002 Jan; 16(1):61-8. PubMed ID: 11856079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New salicylate therapies for ulcerative colitis.
    Bruckstein AH
    Postgrad Med; 1990 Sep; 88(3):79-82, 84, 89. PubMed ID: 1975952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
    Rachmilewitz D
    BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.
    Campieri M; Lanfranchi GA; Bazzocchi G; Brignola C; Sarti F; Franzin G; Battocchia A; Labo G; Dal Monte PR
    Lancet; 1981 Aug; 2(8241):270-1. PubMed ID: 6114321
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term use of mesalamine enemas to induce remission in ulcerative colitis.
    Biddle WL; Miner PB
    Gastroenterology; 1990 Jul; 99(1):113-8. PubMed ID: 1971605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Aminosalicylic acid, 1,000-mg caplets versus 500-mg tablets, in maintenance of remission in ulcerative colitis.
    Odes HS
    J Clin Gastroenterol; 1997 Jun; 24(4):287-8. PubMed ID: 9252863
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral asacol in the treatment of mild to moderate ulcerative colitis: the Nashville experience.
    Pruitt RE; Gremillion DE; Herring RW; Bailey AH; Faust TW; Potter M; Long KM
    J Tenn Med Assoc; 1991 May; 84(5):237. PubMed ID: 2067380
    [No Abstract]   [Full Text] [Related]  

  • 28. Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
    Meyers S; Sachar DB; Present DH; Janowitz HD
    Scand J Gastroenterol Suppl; 1988; 148():29-37. PubMed ID: 2906474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Will there be a next generation of sulfasalazine?
    Goldman P
    Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract]   [Full Text] [Related]  

  • 30. Mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508
    [No Abstract]   [Full Text] [Related]  

  • 31. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis.
    Mulder CJ; Tytgat GN; Weterman IT; Dekker W; Blok P; Schrijver M; van der Heide H
    Gastroenterology; 1988 Dec; 95(6):1449-53. PubMed ID: 2903110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
    Rutgeerts P
    Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral balsalazide (Colazal) for ulcerative colitis.
    Med Lett Drugs Ther; 2001 Jul; 43(1109):62-3. PubMed ID: 11468602
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
    Bresci G; Carrai M; Venturini G; Gambardella L
    Minerva Dietol Gastroenterol; 1990; 36(1):31-3. PubMed ID: 1970855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The local therapy of distal colitis and ulcerative proctitis].
    Scheppach W
    Dtsch Med Wochenschr; 1993 May; 118(20):751-4. PubMed ID: 8099006
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Aminosalicylic acid suppositories in the management of ulcerative colitis.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Torresan F; Tampieri M; Iannone P; Miglioli M; Barbara L
    Dis Colon Rectum; 1989 May; 32(5):398-9. PubMed ID: 2714131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-ASA for ulcerative colitis.
    Meyers S; Janowitz HD
    N Engl J Med; 1988 Jun; 318(24):1620-1. PubMed ID: 3287160
    [No Abstract]   [Full Text] [Related]  

  • 39. Intermittent versus continuous 5-aminosalicylic acid treatment for maintaining remission in ulcerative colitis.
    Bardazzi G; d'Albasio G; Bonanomi AG; Trallori G; Messori A; Amorosi A; Bartoletti L; Morettini A; Pacini F
    Ital J Gastroenterol; 1994 Sep; 26(7):334-7. PubMed ID: 7812025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfasalazine and 5-ASA compounds.
    Allgayer H
    Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.